Literature DB >> 16927832

[Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action].

Lin Wang1, Yu-Jia Mao, Wen-Jie Wang.   

Abstract

AIM: To study the inhibitory action of diacerein on the formation of osteoclasts (OCLs) and their activity in bone resorption as well as the relationship between this action and the expression of osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in MC3T3-E1 cells.
METHODS: A coculture system constituted with MC3T3-E1 cells and bone marrow cells for osteoclasts formation was established in vitro. TRAP-positive and multinucleated cells with three or more nuclei in each cell were counted as osteoclasts and the number of pits formed on the dentine slices was determined to judge the activity of osteoclasts. Western blotting, RT-PCR and flow cytometer were used to detect the expression of OPG and RANKL in MC3T3-E1 cells.
RESULTS: Diacerein significantly inhibited the formation and function of the cultured osteoclasts stimulated by IL-1beta. sRANKL could reverse the effect of diacerein. Diacerein inhibited protein and mRNA expression of RANKL but enhanced those of OPG in MC3T3-E1 cells.
CONCLUSION: Diacerein may inhibit osteoclastic bone destruction through the inhibition of RANKL expression and the increase of OPG expression in MC3T3-E1 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927832

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  3 in total

1.  Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.

Authors:  Erica M TenBroek; Laurie Yunker; Mae Foster Nies; Alison M Bendele
Journal:  Arthritis Res Ther       Date:  2016-01-21       Impact factor: 5.156

2.  Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats.

Authors:  Nan Li; Lu-Ping Qin; Ting Han; Yan-Bin Wu; Qiao-Yan Zhang; Hong Zhang
Journal:  Molecules       Date:  2009-06-08       Impact factor: 4.411

3.  Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts.

Authors:  Yan-Bin Wu; Cheng-Jian Zheng; Lu-Ping Qin; Lian-Na Sun; Ting Han; Lei Jiao; Qiao-Yan Zhang; Jin-Zhong Wu
Journal:  Molecules       Date:  2009-01-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.